The Secretariat-General of industry and small and medium-sized enterprises has established as a key objective of industrial policy to enhance the pharmaceutical and health products through the implementation of industrial research, technological development, innovation in processes and organization, as well as investments aimed at sustainability by improving the efficiency and environmental protection beyond the rules of the union, taking into account both the context of the output of the crisis resulting from the COVID 19 such as the need for a recovery in key ecological, on the basis of climate neutrality and environmental protection.
Access to the page with the regulations
Ayúdenos a mejorar. Si lo desea puede cumplimentar esta encuesta de calidad de nuestros servicios.
Thanks for your comments.